Xebios Diagnostics Group
Xebios Diagnostics Group (now Solabia Xebios GmbH) manufactures ready-to-use culture media and test reagents for microbiological diagnostics, serving water, food, beverage, cosmetics, pharma, and clinical laboratories across Germany and the Netherlands.
- Company typePrivate
- Founded1989
- HeadquartersDüsseldorf, Germany
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Xebios Diagnostics Group does
Xebios Diagnostics Group (now operating as Solabia Xebios GmbH) is a German-domiciled manufacturer of ready-to-use culture media and test reagents for microbiological diagnostics, headquartered in Düsseldorf with additional production sites in Eindhoven and Groningen, the Netherlands. The company produces Fertignährmedien (ready-to-use culture media) and Testreagenzien (test reagents), including selective enrichment broths, chromogenic agars, and specialized reagents for detecting pathogens such as Legionella, E. coli, coliforms, Salmonella, Listeria, and S. aureus. Supporting offerings include dehydrated culture media, the Xebios-App (a mobile and web tool for certificate management, inventory tracking, and QR-code-based product information), TCS Selectrol quality control reference organisms, Sartorius Microsart membrane filtration products distributed as a channel partner, and the COLIKAT RAPID 18-hour rapid test for E. coli/coliform enumeration per DIN EN ISO 9308-2.
The business serves B2B customers across five vertical segments: water testing laboratories (drinking water, mineral water, wastewater), food and beverage manufacturers, cosmetics manufacturers, pharmaceutical manufacturers (GMP compliance, environmental monitoring), and clinical/medical laboratories. Quality control is conducted in conformity with ISO 11133 and Ph. Eur., and customer-specific certificates are provided to reduce or eliminate incoming inspection burden. Differentiated logistics include company-owned delivery vehicles, Just-In-Time delivery, batch reservation, reusable container systems, and shelf service to customer laboratories.
Revenue is generated through direct, sales-led B2B distribution via account managers, website inquiry forms, and online catalog — no public pricing is disclosed. The go-to-market emphasizes a "system partner" positioning that bundles products, QC services, the Xebios-App, and proprietary logistics. In March 2026, Solabia Group (a Paris-headquartered biotechnology platform backed by private equity investor Astorg) announced the acquisition of Xebios Diagnostics Group, integrating it under Solabia Xebios GmbH and combining production capabilities across France, Germany, and the Netherlands. Post-acquisition, the entity is led by Managing Directors Stephane Laugier and Francois Pointurier.
Xebios Diagnostics Group firmographics
Firmographics- Name
- Xebios Diagnostics Group
- Legal name
- Solabia Xebios GmbH
- Website
- https://xebios.de
- Company type
- Private
- Founded year
- 1989
- Operating status
- Acquired
- Headcount range
- 51–100 employees
- Short description
- Xebios Diagnostics Group (now Solabia Xebios GmbH) manufactures ready-to-use culture media and test reagents for microbiological diagnostics, serving water, food, beverage, cosmetics, pharma, and clinical laboratories across Germany and the Netherlands.
- Ownership category
- akta.pro rank
Xebios Diagnostics Group industry classification
Industry- Product category
- Microbiological Diagnostics Consumables
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)
- akta.pro secondary industries
- Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC), Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL), Rapid On-Site Environmental Testing Kits & Instruments (Lateral Flow, PCR, ATP Devices) (AFALAEAK), Microbiological Reference Cultures, Strains & Controls (Food Micro) (AFALAKAF)
Keywords
Where Xebios Diagnostics Group is headquartered
LocationHeadquarters
- HQ city
- Düsseldorf
- HQ country
- Germany
- HQ region
- Europe
Offices3 records
Markets served
Xebios Diagnostics Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Culture Media and Reagents Sales: Sale of ready-to-use and dehydrated culture media, test reagents, and reference organisms for microbiological testing. Products include selective media for pathogens, chromogenic media for indicator organisms, and QC control strains.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Xebios Diagnostics Group product offering
Product offeringCore offering
Xebios Diagnostics Group manufactures and supplies ready-to-use culture media (Fertignährmedien), dehydrated culture media, and microbiological test reagents used by laboratories in water, food and beverage, cosmetics, pharmaceutical, and clinical diagnostics. The portfolio is complemented by rapid tests such as COLIKAT RAPID, the company's own Xebios-App for product information and ordering, and resold third-party consumables including Sartorius Microsart e.motion filtration products and TCS Selectrol Discs quality control reference organisms.
Product overview
Xebios Diagnostics Group operates as a system partner for ready-to-use culture media and test reagents for microbiological diagnostics. The company manufactures products for testing drinking water, food, beverages, cosmetics, pharmaceutical products, and clinical samples for bacterial and viral contamination. The core product line consists of Fertignährmedien (ready-to-use culture media) and Testreagenzien (test reagents), which include various agar plates, broths, and selective enrichment media. Supporting offerings include the Xebios-App (mobile application for certificate management and inventory tracking), TCS Selectrol quality control discs, Sartorius Microsart membrane filtration products, COLIKAT RAPID 18-hour rapid test, dehydrated culture media, quality control services (ISO 11133/Ph. Eur. compliant), and proprietary logistics services. The company operates three production sites in Düsseldorf, Eindhoven (Netherlands), and Groningen (Netherlands) and was acquired by Solabia Group in March 2026.
Differentiator
Problem solved
Functional benefit
Products and services
- Ready-to-use culture media (Fertignährmedien)
Companies that use Xebios Diagnostics Group
Customer profileSegments5 records
Ideal customer profiles1 record
Xebios Diagnostics Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Xebios Diagnostics Group partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- Solabia GroupcoreSolabia Group, a Paris-headquartered biotechnology platform, acquired Xebios Diagnostics Group in March 2026. The acquisition strengthens Solabia's European diagnostics footprint, enhances manufacturing capabilities across France, Germany, and the Netherlands, and provides complementary product portfolios and geographic reach.
- Mibelle BiochemistryminorPart of Solabia's three strategic acquisitions announced in March 2026, alongside Seqens' Botanical Actives and In-Vitro Diagnostics activity. Mibelle Biochemistry is Switzerland-based.
Scale indicators3 records
Recent moves6 records
Expansion highlights4 records
Xebios Diagnostics Group competitors and assessment
Company assessmentDirect peers
- bioMérieux: Global leader in industrial and clinical microbiology, including culture media, reagents, and automated identification/AST platforms. Directly comparable as a manufacturer of ready-to-use culture media and microbiological diagnostic reagents serving the same water, food, pharma, and clinical end-markets, though at significantly larger scale with bundled instrument solutions.
- Merck KGaA / MilliporeSigma: Sells an extensive portfolio of dehydrated and ready-to-use culture media, chromogenic media, and QC reference organisms under the MilliporeSigma brand. Overlaps with Xebios across all five verticals and competes on catalog breadth, regulatory documentation, and global distribution reach.
- Sartorius: Provides membrane filtration products (Microsart) that Xebios resells alongside its culture media, and Sartorius also offers biopharmaceutical quality control solutions including microbiological testing. Comparable as a supplier of complementary water-testing and QC consumables.
Broad incumbents
- Thermo Fisher Scientific: Through its Microbiology and Microbiological Sciences business, offers culture media, prepared media, and diagnostic reagents alongside instruments and consumables. Comparable as a broad incumbent offering overlapping product categories, with greater scale, global reach, and bundled automation capabilities.
- BD (Becton Dickinson): Manufactures BD Prepared Culture Media and BD MAX molecular diagnostics, with a strong clinical microbiology franchise. Competes with Xebios in clinical microbiology culture media and reagent consumables, particularly in hospital laboratories.
- Solabia Group: Parent company post-March 2026 acquisition; Paris-headquartered biotech platform with broader diagnostics, biotechnology, and life science ingredient capabilities. Relevant as the acquirer and as a portfolio platform covering adjacent microbiology, excipients, and diagnostic ingredients.
- Charles River Laboratories: Global CRO and supplier of microbiological testing products, endotoxin detection, and QC organisms used in pharmaceutical and biopharmaceutical manufacturing. Comparable as a broader player serving Xebios's pharmaceutical and clinical end-markets with overlapping QC consumables and testing services.
Emerging players
- HiMedia Laboratories: India-based manufacturer with a broad portfolio of dehydrated and ready-prepared culture media, microbial identification strips, and QC organisms. Comparable as a specialist culture media manufacturer expanding into international markets and competing on price/portfolio breadth.
- Liofilchem: Italian manufacturer of ready-to-use culture media, antimicrobial susceptibility discs, and microbiological diagnostic kits. Comparable as a European mid-sized specialist with similar product mix and regulatory positioning, often competing in the same tenders for water and clinical labs.
- Condalab: Spanish manufacturer specializing in dehydrated and ready-to-use culture media, chromogenic media, and microbiology reagents. Comparable as a regional European specialist serving food, water, clinical, and pharma laboratories with a similar product-to-service model.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Xebios Diagnostics Group social profiles
Digital presenceXebios Diagnostics Group compliance and trust
Trust signalCompliance1 record
Xebios Diagnostics Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Xebios Diagnostics Group leadership team
Management profileNumber of profiles
Profiles3 records
Xebios Diagnostics Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Xebios Diagnostics Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Xebios Diagnostics Group
What does Xebios Diagnostics Group do?
Xebios Diagnostics Group manufactures and supplies ready-to-use culture media (Fertignährmedien), dehydrated culture media, and microbiological test reagents used by laboratories in water, food and beverage, cosmetics, pharmaceutical, and clinical diagnostics. The portfolio is complemented by rapid tests such as COLIKAT RAPID, the company's own Xebios-App for product information and ordering, and resold third-party consumables including Sartorius Microsart e.motion filtration products and TCS Selectrol Discs quality control reference organisms.
Is Xebios Diagnostics Group a public or private company?
Xebios Diagnostics Group is a private company. It is classified as corporate owned and is currently acquired.
When was Xebios Diagnostics Group founded?
Xebios Diagnostics Group was founded in 1989. It employs 51 to 100 people.
Where is Xebios Diagnostics Group based?
Xebios Diagnostics Group is headquartered in Düsseldorf, Germany, in the Europe region.
How does Xebios Diagnostics Group make money?
One revenue line is on record: culture Media and Reagents Sales.
Who are Xebios Diagnostics Group's main competitors?
Direct peers on record are bioMérieux, Merck KGaA / MilliporeSigma and Sartorius. Broad incumbents are Thermo Fisher Scientific, BD (Becton Dickinson), Solabia Group and Charles River Laboratories. Emerging players are HiMedia Laboratories, Liofilchem and Condalab.
Does Xebios Diagnostics Group have an API?
No public API is recorded for Xebios Diagnostics Group.
What industry is Xebios Diagnostics Group in?
Xebios Diagnostics Group's product category is Microbiological Diagnostics Consumables. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAHAAAC, Microbiology & Infectious Disease Diagnostics (Culture/ID/AST). Its NAICS code is 325413 and its SIC code is 2835.